About Unlearn

Unlearn is a healthcare AI company pioneering the use of generative machine learning and patient digital twins to accelerate clinical drug development. Its technology predicts individual health outcomes and simulates potential futures, enabling 'what if?' scenarios to compare treatment effects. By partnering with pharma and biotech innovators, Unlearn helps achieve faster enrollment in AI-powered clinical trials and reduces trial-and-error in medicine. The platform’s patient-centric approach improves decision-making, enhances trial efficiency, and supports personalized medicine. With a mission to eliminate trial and error, Unlearn is building the leading AI company in healthcare to transform drug discovery and patient care.

Platforms:

Feature Highlights

Use Cases

Common
Uncommon
Description
Forecasting patient health outcomes
Comparing relative treatment effects
Accelerating drug development pipelines
Improving clinical trial efficiency
Supporting personalized medicine initiatives